Trial Profile
Efficacy and safety of first line oral therapies, Dimethyl fumarate vs teriflunomide in relapsing-remitting multiple sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2016
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary) ; Teriflunomide (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use